Related references
Note: Only part of the references are listed.Thyroidectomy without radioiodine therapy
Susanne Krome
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2022)
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer
S. Leboulleux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis?
Kyujin Han et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study
Seong Young Kwon et al.
CLINICAL ENDOCRINOLOGY (2021)
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)
Raffaella Forleo et al.
THYROID (2021)
Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?
Debora L. S. Danilovic et al.
THYROID (2020)
Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey
Christoph Reiners et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma
Fuxin Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients
Freba Ahmaddy et al.
CANCERS (2020)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Filetti et al.
ANNALS OF ONCOLOGY (2019)
Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine
P. W. Rosario et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
Hakim-Moulay Dehbi et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Impact of Minimal Extrathyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-Analysis
Talia Diker-Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer
Samantha Tam et al.
THYROID (2018)
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor
M. G. Castagna et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer
Huan Yan et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer
Chang-Hee Lee et al.
PLOS ONE (2018)
Prognostic Value of Stimulated Thyroglobulin Levels at the Time of Radioiodine Administration in Differentiated Thyroid Cancer
Mathieu Spaas et al.
EUROPEAN THYROID JOURNAL (2018)
Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Mijin Kim et al.
CLINICAL ENDOCRINOLOGY (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis
Yingjie Zhang et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
Management of Invasive Differentiated Thyroid Cancer
Iain J. Nixon et al.
THYROID (2016)
Incidence of Nonthyroidal Primary Malignancy and the Association with 131I Treatment in Patients with Differentiated Thyroid Cancer
Dania Hirsch et al.
THYROID (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma
Geum-Cheol Jeong et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer
Ewa Ruel et al.
ENDOCRINE (2016)
Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer
Steven Orlov et al.
ENDOCRINE (2015)
Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients
Hadiza S. Kazaure et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Selective Use of Radioactive Iodine in Intermediate-Risk Papillary Thyroid Cancer
Iain J. Nixon et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2012)
Combination of Initial Stimulation Thyroglobulins and Staging System by Revised ATA Guidelines Can Elaborately Discriminate Prognosis of Patients With Differentiated Thyroid Carcinoma After High-Dose Remnant Ablation
Min-Hee Kim et al.
CLINICAL NUCLEAR MEDICINE (2012)
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
Ujjal Mallick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition
Sin-Ming Chow et al.
ENDOCRINE-RELATED CANCER (2006)
Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma
Neil Bhattacharyya et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2006)
Share Paper
